Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pharmaxis Ltd ADR (PXSLY)

Pharmaxis Ltd ADR (PXSLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pharmaxis Ltd ADR 20 RODBOROUGH ROAD FRENCHS FOREST C3 2086 AUS

www.pharmaxis.com.au P: 61-2-9454-7200

Description:

Pharmaxis develops innovative pharmaceutical products to treat human respiratory and autoimmune diseases. Its development pipeline of products include AridolTM for asthma, BronchitolTM for cystic fibrosis and chronic obstructive pulmonary disease and PXS64 for multiple sclerosis.

Key Statistics

Overview:

Market Capitalization, $K 26,532
Shares Outstanding, K 30,150
Annual Sales, $ 8,750 K
Annual Net Income, $ -9,360 K
60-Month Beta 1.22
% of Institutional Shareholders 0.00%
Float, K 30,150
% Float 100.00%

Growth:

1-Year Return -9.28%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth -82.36%
5-Year Earnings Growth -145.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 10/01/20
Earnings Per Share ttm 0.00
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PXSLY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -106.97%
Debt/Equity 2.82
Price/Sales 3.27
Price/Cash Flow N/A
Price/Book 16.77
Book Value/Share 0.00
Interest Coverage -7.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar